Scott Scarneo

Eydis Bio, Inc.

NIH Rank #7207
  • Early Career

NIH Funding · FY2024

Total Funding
$1.7M
Fiscal year 2024
Grants Awarded
2
Active NIH grants
National Rank
#7,207
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.7M across 2 grants · National rank #7207.

Top grants by award amount

Scott Scarneo's NIH grant portfolio, ranked by award amount.

  • 1R44HL170834-01A1R44
    Novel compounds for the treatment of systemic sclerosis-associated interstitial lung disease
    $1.2M
    award amount
  • 1R41AG090212-01R41
    Development of orally bioavailable and blood-brain barrier penetrant, small molecule TAK1 inhibitors as a novel treatment for Alzheimer's Disease
    $506.3K
    award amount

Affiliation

Institutions that have administered grants for Scott Scarneo.

Affiliated with Eydis Bio, Inc. (NC).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Eydis Bio, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7207

Related investigators

Other NIH-funded PIs frequently associated with Scott Scarneo.